{
 "company": {
  "id": "vertex-pharmaceuticals",
  "name": "Vertex Pharmaceuticals Incorporated",
  "country": "US",
  "template": "corporate",
  "cik": "0000875320",
  "tickers": [
   "VRTX"
  ],
  "sources": "10-K and 10-Q filings with the SEC, published by SEC EDGAR",
  "sector": "Health care",
  "industry": "Biotechnology"
 },
 "snapshot": "FY2026Q3_3e58470d",
 "schema": "annalist.dataset/0.1",
 "dataset_sha256": "3e58470d5c2b9d172f2fbd1573019a46fd9fce41bbc3a706e670cf03f1edffbf",
 "as_of": {
  "period": "FY2026 Q3",
  "period_end": "2026-09-30",
  "release_date": "2026-11-03"
 },
 "published_at": "2026-11-06T02:51:44+00:00",
 "coverage": {
  "first_fiscal_year": 2020,
  "latest_period": "FY2026 Q3",
  "rule": "fiscal years ending on or after 2020-12-31"
 },
 "conventions": {
  "amounts": "US dollars as reported, not scaled; per-share items in US dollars per share; share counts in shares; pure items as fractions",
  "signs": "revenue, expenses, taxes and payments are positive amounts; operating, investing and financing cash-flow totals are negative when cash flows out",
  "fiscal_year": "the company's own fiscal-year label; start and end dates are given for every period",
  "period_label": "FY<year> Q<n>",
  "quarters": "a quarter that the filings do not report on its own, such as a fourth quarter, is derived from the figures of the filings",
  "restatements": "each value comes from the latest filing that reports the period; earlier different values are listed in restatements",
  "comparison": "a change against the same period a year earlier compares 2 figures of one basis, as the latest report that presents both periods gives them, so that a restatement or a stock split between 2 reports does not count as a change; where these figures differ from the published ones, the row of the later period gives them under comparison, with their sources and the fiscal year of the report (basis), and a comparison of null means that no report presents both",
  "definitions": "each item keeps one definition across periods",
  "withheld": "a value that contradicts the definition of its item, or that the filings report in contradiction, is withheld: it is empty and listed in withheld with its reason and sources",
  "source_ids": "<form>:<accession number>; see documents",
  "events": "corporate events found in the filings since 2020, such as acquisitions, disposals, stock splits, restatements and changes of name; each names its type and its source documents",
  "notes": "items with group note come from the notes to the financial statements; a note item that a filing does not report is empty, which differs from a reported zero; pure items are fractions, so 0.045 means 4.5%",
  "debt": "total debt counts each borrowing once; a balance-sheet date at which the company has no debt carries nil debt",
  "methods": "method is reported, or derived where the figure is calculated from figures of the documents listed",
  "published_at": "the time, in UTC, at which Annalist wrote the snapshot to the site for the first time; the snapshot of a company that a reader could cite on a date is the latest whose published_at is not after that date"
 },
 "validation": {
  "total": 262,
  "failed": 0,
  "warnings": 5
 },
 "adjustments": [],
 "restatements": 117,
 "guidance": null,
 "statements": [
  {
   "statement": "income_statement",
   "frequency": "quarterly",
   "section": "pl_quarterly",
   "url": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/statements/pl_quarterly.json",
   "rows": 27,
   "first": "FY2020 Q1",
   "last": "FY2026 Q3",
   "items": [
    "cost_of_revenue",
    "dps_declared",
    "eps_basic",
    "eps_diluted",
    "gross_profit",
    "income_tax",
    "interest_expense",
    "nci_profit",
    "net_income",
    "net_income_common",
    "net_income_incl_nci",
    "operating_income",
    "operating_lease_cost",
    "pretax_income",
    "revenue",
    "rnd",
    "sga",
    "shares_basic",
    "shares_diluted"
   ]
  },
  {
   "statement": "income_statement",
   "frequency": "annual",
   "section": "pl_annual",
   "url": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/statements/pl_annual.json",
   "rows": 6,
   "first": "FY2020",
   "last": "FY2025",
   "items": [
    "cost_of_revenue",
    "dps_declared",
    "eps_basic",
    "eps_diluted",
    "gross_profit",
    "income_tax",
    "interest_expense",
    "nci_profit",
    "net_income",
    "net_income_common",
    "net_income_incl_nci",
    "operating_income",
    "operating_lease_cost",
    "pretax_income",
    "revenue",
    "rnd",
    "sga",
    "shares_basic",
    "shares_diluted"
   ]
  },
  {
   "statement": "balance_sheet",
   "frequency": "quarter_end",
   "section": "balance_sheet",
   "url": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/statements/balance_sheet.json",
   "rows": 27,
   "first": "FY2020 Q1",
   "last": "FY2026 Q3",
   "items": [
    "accounts_payable",
    "accrued_taxes_current",
    "cash",
    "commercial_paper",
    "current_assets",
    "current_liabilities",
    "debt_current",
    "debt_maturity_after_y5",
    "debt_maturity_y1",
    "debt_maturity_y2",
    "debt_maturity_y3",
    "debt_maturity_y4",
    "debt_maturity_y5",
    "equity_method_investments",
    "equity_parent",
    "equity_total",
    "goodwill",
    "intangibles",
    "inventory",
    "liabilities_and_equity",
    "long_term_debt",
    "long_term_investments",
    "nci",
    "operating_lease_discount_rate",
    "operating_lease_imputed_interest",
    "operating_lease_liability",
    "operating_lease_liability_current",
    "operating_lease_liability_noncurrent",
    "operating_lease_payments_total",
    "operating_lease_payments_y1",
    "ppe_net",
    "preferred_stock",
    "receivables",
    "retained_earnings",
    "shares_outstanding",
    "short_term_borrowings",
    "short_term_investments",
    "temporary_equity",
    "total_assets",
    "total_liabilities"
   ]
  },
  {
   "statement": "cash_flow",
   "frequency": "quarterly",
   "section": "cf_quarterly",
   "url": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/statements/cf_quarterly.json",
   "rows": 27,
   "first": "FY2020 Q1",
   "last": "FY2026 Q3",
   "items": [
    "amortisation_intangibles",
    "buybacks",
    "capex",
    "cff",
    "cfi",
    "cfo",
    "change_contract_liabilities",
    "change_inventories",
    "change_payables",
    "change_receivables",
    "d_and_a",
    "deferred_tax",
    "depreciation",
    "dividends_paid",
    "goodwill_impairment",
    "interest_paid",
    "proceeds_debt_issuance",
    "proceeds_equity_issuance",
    "sbc",
    "taxes_paid"
   ]
  },
  {
   "statement": "cash_flow",
   "frequency": "annual",
   "section": "cf_annual",
   "url": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/statements/cf_annual.json",
   "rows": 6,
   "first": "FY2020",
   "last": "FY2025",
   "items": [
    "amortisation_intangibles",
    "buybacks",
    "capex",
    "cff",
    "cfi",
    "cfo",
    "change_contract_liabilities",
    "change_inventories",
    "change_payables",
    "change_receivables",
    "d_and_a",
    "deferred_tax",
    "depreciation",
    "dividends_paid",
    "goodwill_impairment",
    "interest_paid",
    "proceeds_debt_issuance",
    "proceeds_equity_issuance",
    "sbc",
    "taxes_paid"
   ]
  }
 ],
 "ratios": {
  "url": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/ratios/index.json",
  "template": "corporate",
  "ratios": 68,
  "values": 1603,
  "frequencies": [
   "annual",
   "quarterly",
   "ttm"
  ],
  "engine": "annalist 0.1.0 (ratios 0.8.0)",
  "series": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/ratios/series.json"
 },
 "documents": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/documents.json",
 "calendar": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/calendar.json",
 "files": [
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/balance_sheet.csv",
   "bytes": 127169,
   "sha256": "3ed2ad91483f53f48f3dc38976defeab0c035141e3816057a47dd3e211e89c62"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/calendar.json",
   "bytes": 4263,
   "sha256": "41ded973c7a873c07b2f9a4a0dda1ca2f4193b5791d024b020f6271f212b2938"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/cf_annual.csv",
   "bytes": 15775,
   "sha256": "fc5299301fa4a8c521c9405bc36605c4ca64f70bd1f48042dbd7a0ee11bf5764"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/cf_quarterly.csv",
   "bytes": 78324,
   "sha256": "e0d6baed4955f250ecf7859b81f017955d3e9f82b48361afe6293c24573bd450"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/dataset.json",
   "bytes": 283804,
   "sha256": "a6529eae9d4180fe4bca81cdff9ef37038f3953b145dcd9015a99dc85671c9e0"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/documents.csv",
   "bytes": 6605,
   "sha256": "c9a6296f534725d2edc0bec83fadfa89c600602b141fd812e7fe6285cce84590"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/documents.json",
   "bytes": 10649,
   "sha256": "7cd2ed66c33e0095a958874cd1ad389f852e33ec7c1ec1a34fa2055d6cce8b37"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/model_inputs.json",
   "bytes": 7007,
   "sha256": "6ecb53e4503a7e49b31ed99130e90f57f02370ca4eb54959a24a1ce43cb05792"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/pl_annual.csv",
   "bytes": 15251,
   "sha256": "bd016265cd8bbb8fcb073016f96d6b4b279d2273af5a1064a9ac8f6ba9833cc2"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/pl_quarterly.csv",
   "bytes": 68959,
   "sha256": "7128887bed086afd483c4b5df91ccf842117757335997064b338f8bdee093371"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/ratios/annual.json",
   "bytes": 188273,
   "sha256": "9d74920f5a4a3f6a9e4456dc44d1c2b257d50d516f606cd4cfb7c472c717c5e6"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/ratios/index.json",
   "bytes": 40275,
   "sha256": "860af68b62048df20497c5a041d79317fcbd1fdbd4a68e9a64cc51fc779d1d90"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/ratios/quarterly.json",
   "bytes": 233439,
   "sha256": "170de90058e07d7b90d5ce5b600fed67ac3781127cf0a48ee58ddcc8bf2cac62"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/ratios/series.json",
   "bytes": 132833,
   "sha256": "dac1f3e3ba64084c10d132729e1e08d691bd7034edb847f24a1fad6732b62dfc"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/ratios/ttm.json",
   "bytes": 727167,
   "sha256": "7bcfdc884a9efa36d46602f7ac499956239f09e638a68dbdc38eea386aaaa7fd"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/ratios.csv",
   "bytes": 595983,
   "sha256": "99ea7b881aa30a31fd77a5cdda97e931eec5965752aff80461ed971884d6ef4e"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/ratios.json",
   "bytes": 1024643,
   "sha256": "25ab8b315b257b40407b7d1fbe9fcdfb57b57db268da34fe2e94f547157c3621"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/restatements.csv",
   "bytes": 17615,
   "sha256": "30c8bb62082652cb91b8f648a78ae98ea068fb472fe2b0be26170b4be6475918"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/statements/balance_sheet.json",
   "bytes": 87544,
   "sha256": "32663ea1c4a732772a84d3e7d44759a174ba465a85230e997d56d394d95b08b0"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/statements/cf_annual.json",
   "bytes": 15780,
   "sha256": "b74f1a92e7af48a4c665d4841226ef44de21d0e8b5d1138f5bbc1db6aa2a20a9"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/statements/cf_quarterly.json",
   "bytes": 62893,
   "sha256": "afebcfbea709cc3ea7111511e1fb4f8f89a9eb31a5b8bb070ebb2e4392da09d2"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/statements/pl_annual.json",
   "bytes": 15447,
   "sha256": "0db7d7d5c0eb048cbbf2a9f75c2045748af25a2c4de8d41bb3ca7be01a47dff0"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/statements/pl_quarterly.json",
   "bytes": 52156,
   "sha256": "96bf894635c1c691662fef334c16c7b6632dca9b042f88e2ee07f44ac013749f"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/tables.json",
   "bytes": 10533,
   "sha256": "2cc4fd877e75cc3cf5ce2e1398e32c2dac7882fc6f5b0dd82e3f60337681de2c"
  },
  {
   "path": "/api/v1/companies/vertex-pharmaceuticals/snapshots/FY2026Q3_3e58470d/validation.json",
   "bytes": 3320,
   "sha256": "0ca1f7cbebd69857c89097e993691d93e82aa792f0d05394ac207ff63bed36bf"
  }
 ],
 "citation": {
  "format": "Annalist, {company name}, snapshot {company id}/{snapshot id} (as of {period}); {item label}, {period}; source {document id} ({document url})",
  "example": "Annalist, Vertex Pharmaceuticals Incorporated, snapshot vertex-pharmaceuticals/FY2026Q3_3e58470d (as of FY2026 Q3); <item label>, <period>; source <document id> (<document url>)",
  "note": "Document ids name the official document of each figure; documents.json gives its URL and SHA-256."
 }
}